semaglutide or tirzepatide vs. Semaglutide: What's the Difference? Tirzepatide vs. Semaglutide: What You

I., Santerre R

It is not great

Week 48 Typical Outcomes Excellent Responders (Top 25%) Weight loss: 27-31% (59-68 pounds for 220-pound starter) Characteristics: Perfect adherence, implemented all protocols, resistance training consistent, high protein intake maintained Good Responders (Middle 50%) Weight loss: 21-27% (46-59 pounds for 220-pound starter) Characteristics: Good adherence with occasional lapses, followed core protocols, moderate activity Modest Responders (Bottom 25%) Weight loss: 16-21% (35-46 pounds for 220-pound starter) Characteristics: Variable adherence, minimal dietary modification, limited activity, or metabolic resistance factors What Happens After Week 48

This leads to a significant reduction in food cravings and food noise, while helping you feel satisfied with smaller portions

CNS Drugs, 33(12), 11671186

Tirzepatide, as a dual GIP/GLP-1 receptor agonist, shows no increased UTI risk in clinical trials